343,021 Shares in Haleon plc (NYSE:HLN) Acquired by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC purchased a new stake in Haleon plc (NYSE:HLN) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 343,021 shares of the company’s stock, valued at approximately $2,833,000.

Several other institutional investors also recently made changes to their positions in the stock. International Assets Investment Management LLC acquired a new position in shares of Haleon during the fourth quarter worth about $198,000. Sequoia Financial Advisors LLC boosted its holdings in Haleon by 232.4% in the 4th quarter. Sequoia Financial Advisors LLC now owns 219,548 shares of the company’s stock worth $1,804,000 after acquiring an additional 153,506 shares during the period. Cerity Partners LLC grew its position in Haleon by 312.6% in the fourth quarter. Cerity Partners LLC now owns 152,235 shares of the company’s stock valued at $1,253,000 after acquiring an additional 115,342 shares in the last quarter. Simplicity Solutions LLC raised its stake in shares of Haleon by 82.1% during the fourth quarter. Simplicity Solutions LLC now owns 22,733 shares of the company’s stock valued at $187,000 after purchasing an additional 10,247 shares during the period. Finally, Hoxton Planning & Management LLC acquired a new position in shares of Haleon during the fourth quarter worth $85,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HLN has been the topic of several analyst reports. HSBC began coverage on shares of Haleon in a research note on Wednesday, April 17th. They set a “buy” rating on the stock. The Goldman Sachs Group cut Haleon from a “buy” rating to a “neutral” rating in a research note on Tuesday. Finally, Berenberg Bank assumed coverage on Haleon in a research note on Tuesday. They set a “buy” rating for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, Haleon has a consensus rating of “Moderate Buy”.

Haleon Stock Up 2.0 %

HLN stock traded up $0.19 during mid-day trading on Friday, hitting $9.81. 4,278,124 shares of the company were exchanged, compared to its average volume of 5,233,505. The firm has a fifty day simple moving average of $8.77 and a 200 day simple moving average of $8.48. The company has a market capitalization of $44.79 billion, a PE ratio of 32.70, a price-to-earnings-growth ratio of 2.69 and a beta of 0.24. Haleon plc has a twelve month low of $7.70 and a twelve month high of $9.83. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). Haleon had a return on equity of 19.85% and a net margin of 9.71%. The firm had revenue of $3.50 billion during the quarter, compared to analyst estimates of $3.55 billion. During the same quarter last year, the business posted $0.08 earnings per share. On average, research analysts forecast that Haleon plc will post 0.47 earnings per share for the current fiscal year.

Haleon Cuts Dividend

The company also recently declared a semi-annual dividend, which will be paid on Thursday, September 19th. Investors of record on Friday, August 16th will be given a dividend of $0.0514 per share. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, August 16th. Haleon’s dividend payout ratio is currently 33.33%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.